The transaction is expected to close in the second quarter of 2025, which will include AstraZeneca will buying all outstanding equity in EsoBiotec on a cash and debt-free basis
Browsing: Pharmaceuticals
Marius Pharmaceuticals, which helped secure FDA removal of Black Box Warning, says regulatory shift marks a milestone for patient access and treatment options.
Big pharma in the United States seems to be pivoting to China for their biotechnology and manufacturing needs
Raising manufacturing and R&D costs would lead to an increase in patient costs as well. It would also make it difficult to raise capital for early-stage healthcare companies
While Journavx marks progress in non-opioid pain treatment, its modest effectiveness highlights the ongoing challenge of finding alternative pain relief solutions.
Bisni Narayanan is the first South Asian-origin President of the CPA since its inception in 1876
Trupill’s Sid Viswanathan is back with a new pharmacy venture focused on HIV, Alchemy.
Tipirneni has been the CEO of Morphic since 2015.